In contrast to these pro-fibrotic MMPs, animal models suggest that augmented levels of MMP1 decrease fibroplasia in liver, muscle and heart [46–48], while MMP2 decreased type I collagen production in experimental liver fibrosis [49]. The gene discussed is MMP2; the disease is Hepatic fibrosis.